Organovo Holdings Inc (NYSEMKT:ONVO) Achieves Liver Functions In Manufactured Tissues

Boston, MA 10/24/2013 (wallstreetpr) –¬†Organovo Holdings Inc (NYSEMKT:ONVO) is an organization founded in 2007 for developing artificial organs or tissues for both research and treatment of several ailments. On October 23, the company announced that it has achieved liver functionality in a 3D imprinted tissue and that these functions can be retained up to 40 […]

Three-Dimensional Bioprinter’s Potential Revives Interest In Organovo Holdings (ONVO)

The developer of the NovoGen MMX Bioprinter, Organovo Holdings (OTC: ONVO), continued to attract traders following an “outperform” rating a week ago from Zacks Small Cap Research. In yesterday’s trading session, the share price rose by $0.07 to $2.23 in the first hour of trading and resisted short sellers for the rest of the day. […]

Organovo Holdings Sees 16% Gain Today After Announcing Relocation, New Facility Last Week (ONVO)

Organovo Holdings (OTC: ONVO), the first-ever 3-D tissue technology company, enjoyed a huge gain today after a month of changes and news surrounding the company. Last week, on July 17, 2012, Organovo Holdings announced a move to a 15,539 sq. ft. facility in San Diego, California. The facility includes a lab, clean room and office […]